Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

NCT02740790 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus

Interventions

BIOLOGICAL: HPV vaccine
BIOLOGICAL: Placebo

Sponsor

Shanghai Zerun Biotechnology Co.,Ltd